Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FHVQX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,678
Award facts
- Contract value 100% obligated
- $16,678.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,678.36 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, a prescription medication commonly used in oncology treatment. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a direct supply of pharmaceutical products to support Department of Defense healthcare facilities. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a full and open basis despite its status as a woman-owned small business.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. As a pharmaceutical wholesaler based in Park Ridge, Illinois, DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's established portfolio with the Defense Logistics Agency demonstrates its capability to fulfill specialized pharmaceutical requirements across diverse product categories, positioning it as a reliable vendor for the Department of Defense's medication and medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FHVQX?
SPE2DB25FHVQX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FHVQX worth?
The government has obligated $16,678 on SPE2DB25FHVQX.
Is contract SPE2DB25FHVQX an order under another contract?
Yes. SPE2DB25FHVQX is a delivery order under SPE2DB24D9230, an indefinite delivery contract.
Was contract SPE2DB25FHVQX competed?
The extent of competition for SPE2DB25FHVQX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award